About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Bcl2l14tm1.1Boui
targeted mutation 1.1, Philippe Bouillet
MGI:6470550
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Bcl2l14tm1.1Boui/Bcl2l14tm1.1Boui involves: C57BL/6 MGI:6470551
cx2
ApcMin/Apc+
Bcl2l14tm1.1Boui/Bcl2l14tm1.1Boui
involves: C57BL/6 * C57BL/6J MGI:6470552


Genotype
MGI:6470551
hm1
Allelic
Composition
Bcl2l14tm1.1Boui/Bcl2l14tm1.1Boui
Genetic
Background
involves: C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Bcl2l14tm1.1Boui mutation (0 available); any Bcl2l14 mutation (20 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• mice injected with the alkylating mutagen azoxymethane (AOM) and repetitively administered dextran sulfate sodium (DSS) show earlier appearance of colonic tumors that grow larger than in wild-type mice, with overall colonic tumor number and burden increased indicating accelerated progression of colitis-associated cancer
• however, aged mice do not develop spontaneous tumors in the GI tract
• mice treated with AOM and DSS to induce colitis-associated cancer show similar tumor epithelial proliferation and apoptosis as wild-type mice and a similar level of tumor-infiltrating CD45+ leukocytes
• following acute DSS challenge, mice show no changes in the influx of T cells or macrophages in the colonic lamina propria compared to wild-type mice

digestive/alimentary system
N
• mice exhibit normal colonic crypt architecture and normal colonic epithelial cell proliferation and apoptosis
• an increase in the ability of colon and small intestine epithelial single cells to generate colono-spheroids is seen, however no difference in the number of organoids formed is seen
• mice exhibit accelerated progression of colitis-associated cancer following AOM and DSS treatment
• mice treated with DSS to induce colitis show altered colon mucin scaffolding network
• however, mice with DSS-induced colitis show no differences from wild-type mice in weight, colitis scores or colon lengths

homeostasis/metabolism
• following acute DSS challenge, mice show no changes in the influx of T cells or macrophages in the colonic lamina propria compared to wild-type mice
• mice injected with the alkylating mutagen azoxymethane (AOM) and repetitively administered dextran sulfate sodium (DSS) show earlier appearance of colonic tumors that grow larger than in wild-type mice, with overall colonic tumor number and burden increased indicating accelerated progression of colitis-associated cancer
• however, aged mice do not develop spontaneous tumors in the GI tract
• mice treated with AOM and DSS to induce colitis-associated cancer show similar tumor epithelial proliferation and apoptosis as wild-type mice and a similar level of tumor-infiltrating CD45+ leukocytes

immune system
• mice exhibit accelerated progression of colitis-associated cancer following AOM and DSS treatment
• mice treated with DSS to induce colitis show altered colon mucin scaffolding network
• however, mice with DSS-induced colitis show no differences from wild-type mice in weight, colitis scores or colon lengths

normal phenotype
• mice appear normal, exhibit normal reproductive behavior and produce normal litter sizes, show no obvious defects in the intestines or mammary development during pregnancy, and have normal hematopoietic cell subset composition and splenic dendritic cell development and apoptosis




Genotype
MGI:6470552
cx2
Allelic
Composition
ApcMin/Apc+
Bcl2l14tm1.1Boui/Bcl2l14tm1.1Boui
Genetic
Background
involves: C57BL/6 * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
ApcMin mutation (12 available); any Apc mutation (154 available)
Bcl2l14tm1.1Boui mutation (0 available); any Bcl2l14 mutation (20 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• mice develop colon tumors but show no difference in overall number or size of colon tumors in the proximal, middle, or distal small intestine compared to single heterozygous ApcMin mice and no difference in tumor epithelial proliferation

digestive/alimentary system
• mice develop colon tumors but show no difference in overall number or size of colon tumors in the proximal, middle, or distal small intestine compared to single heterozygous ApcMin mice and no difference in tumor epithelial proliferation





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
05/07/2024
MGI 6.23
The Jackson Laboratory